Capsaicin 0.00025 MG/MG / menthol 0.1 MG/MG Topical Gel [Capzasin Quick Relief] — RxCUI 1043539
RxNorm drug concept · Semantic branded drug
RxCUI 1043539
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1043539
Official nameCapsaicin 0.00025 MG/MG / menthol 0.1 MG/MG Topical Gel [Capzasin Quick Relief]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asCapzasin Quick Relief (capsaicin 0.025 % / menthol 10 % ) Topical Gel; CAPZASIN Quick Relief 0.025 % / 10 % Topical Gel
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Capsaicin Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It gives temporary relief of minor aches and pains in muscles and joints. That includes pain from simple backache, arthritis, strains, bruises and sprains.
- Clean and dry the area, then put the patch on intact skin right after taking it out of the pouch. Adults can use up to 3 patches a day, one at a time, and each should come off with...
- You may notice a burning feeling, and warm water, sweat or heat can make it stronger. Avoid use within an hour before or after a shower, bath, sauna or hard exercise. Never use it...
- Keep it off your face, eyes, other mucous membranes, and any wounds or irritated, broken, sunburned or chapped skin. If it gets in your eyes, rinse continually with cool water and...
🕸️ Concept Web — How Capsaicin 0.00025 MG/MG / menthol 0.1 MG/MG Topi... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Capsaicin 0.00025 MG/MG / menthol 0.1 MG/MG Topical Gel [Capzasin Quick Relief]
RxCUI 1043539 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Capsaicin
1992IN -
Menthol
6750IN -
Capsaicin / menthol
1007122MIN
-
Capsaicin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Capzasin Quick Relief
898523BN
-
Capzasin Quick Relief
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Capsaicin / menthol Topical Gel
438288SCDF -
Capsaicin / menthol Topical Product
1155436SCDG -
Capsaicin / menthol Topical Gel [Capzasin Quick Relief]
1043538SBDF -
Capzasin Quick Relief Topical Product
1173671SBDG -
Topical Gel
346286DF -
Topical Product
1151122DFG
-
Capsaicin / menthol Topical Gel
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Capsaicin 0.00025 MG/MG / menthol 0.1 MG/MG Topical Gel
855923SCD -
Capsaicin 0.00025 MG/MG
329253SCDC -
Menthol 0.1 MG/MG
384557SCDC -
Capsaicin 0.00025 MG/MG / menthol 0.1 MG/MG [Capzasin Quick Relief]
1043537SBDC
-
Capsaicin 0.00025 MG/MG / menthol 0.1 MG/MG Topical Gel
Showing up to 8 concepts per family — 14 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Capsaicin 0.00025 MG/MG / menthol 0.1 MG/MG Topical Gel
SCD · 855923 -
Capsaicin 0.00025 MG/MG
SCDC · 329253 -
Menthol 0.1 MG/MG
SCDC · 384557 -
Capsaicin / menthol Topical Gel
SCDF · 438288 -
Capsaicin / menthol Topical Product
SCDG · 1155436
Brand-Name Concepts
-
Capsaicin 0.00025 MG/MG / menthol 0.1 MG/MG [Capzasin Quick Relief]
SBDC · 1043537 -
Capsaicin / menthol Topical Gel [Capzasin Quick Relief]
SBDF · 1043538 -
Capzasin Quick Relief Topical Product
SBDG · 1173671 -
Capzasin Quick Relief
BN · 898523
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 1043539 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 41167-7516-00 | 1 TUBE, WITH APPLICATOR in 1 CARTON (41167-7516-0) / 42.5 g... | Capzasin Quick Relief | Chattem, Inc. | 2008-12-01 |
Observed labelers:
Chattem, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.